|
1
|
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.
|
Genome Biol
|
2013
|
2.04
|
|
2
|
Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.
|
Mol Cell Biol
|
2005
|
1.51
|
|
3
|
The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex.
|
J Biol Chem
|
2006
|
1.41
|
|
4
|
Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility.
|
J Biol Chem
|
2004
|
1.37
|
|
5
|
Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b.
|
Circulation
|
2007
|
1.27
|
|
6
|
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
|
Circulation
|
2011
|
1.18
|
|
7
|
The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit.
|
J Biol Chem
|
2005
|
1.14
|
|
8
|
Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1).
|
J Biol Chem
|
2004
|
1.12
|
|
9
|
Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
|
Circ Res
|
2009
|
1.11
|
|
10
|
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility.
|
Circ Res
|
2007
|
1.10
|
|
11
|
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
|
Am J Physiol Heart Circ Physiol
|
2011
|
1.10
|
|
12
|
Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
|
Circ Res
|
2010
|
1.06
|
|
13
|
Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium.
|
J Biol Chem
|
2009
|
0.96
|
|
14
|
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain.
|
J Biol Chem
|
2011
|
0.93
|
|
15
|
Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
|
Circulation
|
2009
|
0.92
|
|
16
|
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
|
Circ Heart Fail
|
2013
|
0.91
|
|
17
|
Development and characterization of a novel fluorescent indicator protein PMCA4-GCaMP2 in cardiomyocytes.
|
J Mol Cell Cardiol
|
2013
|
0.83
|
|
18
|
Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells.
|
Carcinogenesis
|
2012
|
0.83
|
|
19
|
Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload.
|
J Mol Cell Cardiol
|
2011
|
0.82
|
|
20
|
The emergence of plasma membrane calcium pump as a novel therapeutic target for heart disease.
|
Mini Rev Med Chem
|
2006
|
0.82
|
|
21
|
Local signals with global impacts and clinical implications: lessons from the plasma membrane calcium pump (PMCA4).
|
Biochim Biophys Acta
|
2010
|
0.82
|
|
22
|
Sperm phenotype of mice carrying a gene deletion for the plasma membrane calcium/calmodulin dependent ATPase 4.
|
Mol Cell Endocrinol
|
2006
|
0.81
|
|
23
|
Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.
|
J Am Heart Assoc
|
2014
|
0.81
|
|
24
|
Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesis.
|
J Biol Chem
|
2011
|
0.78
|
|
25
|
Circulating Histone Concentrations Differentially Affect the Predominance of Left or Right Ventricular Dysfunction in Critical Illness.
|
Crit Care Med
|
2016
|
0.78
|
|
26
|
Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria.
|
J Pharm Pharm Sci
|
2013
|
0.77
|
|
27
|
Ras-association domain family member 1A (RASSF1A)-where the heart and cancer meet.
|
Trends Cardiovasc Med
|
2009
|
0.76
|